Alkermes plc Overview
Alkermes plc (ALKS) has a P/E ratio of 108.26, above the Healthcare sector average of 19.01.
Get informed when a big investor buys or sells
+ Follow108.26
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for ALKS is 108.26. That is above the Healthcare sector average of 19.01. Investors often review this figure alongside Alkermes plc's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, ALKS currently prints 108.26 for P/E ratio, while the sector average sits near 19.01. That is roughly 469.5% above the sector mean. Large gaps often invite a closer look at Alkermes plc's growth, margins, and balance sheet.
A P/E ratio of 108.26 for Alkermes plc is not 'good' or 'bad' on its own. Compare it with the peer average (19.01) and with ALKS's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting ALKS's P/E ratio (108.26), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Alkermes plc's P/E ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
